Trial intelligence / Profile preview

Caffeine as Adjuvant to Opioids in Cancer Pain

NCT00879775Phase 2Completed

Sponsor
National Research Foundation of Korea
Start
Apr 2009
Primary completion
Jul 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of caffeine in cancer pain, sponsored by National Research Foundation of Korea. Started Apr 2009; status: completed.

02

Drugs

caffeine
03

Conditions

cancer pain

Beyond the preview

Go deeper on NCT00879775.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00879775.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call